Cargando…
Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment
PURPOSE: To identify incidence and risk factors of recurrence after discontinuation of successful antimuscarinic therapy in patients with overactive bladder (OAB). MATERIALS AND METHODS: This was a prospective, multicenter trial. Patients who had antimuscarinic agents for more than 12 weeks and show...
Autores principales: | Kim, Aram, Lee, Kyu-Sung, Kim, Tae Beom, Kim, Hyung Joon, Yoo, Eun Sang, Yun, Jong-Hyun, Kim, Duk Yoon, Jung, Suk Gun, Lee, Jun Taik, Kim, Jung Man, Oh, Cheol Kyu, Shin, Ju Hyun, Jeon, Seung Hyun, Lee, Seong Ho, Han, Chang Hee, Lee, Dong Hwan, Cho, Hyuk Jin, Choo, Myung-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240281/ https://www.ncbi.nlm.nih.gov/pubmed/28097267 http://dx.doi.org/10.4111/icu.2017.58.1.42 |
Ejemplares similares
-
Prevalence and Treatment Efficacy of Genitourinary Mycoplasmas in Women with Overactive Bladder Symptoms
por: Lee, Young-Suk, et al.
Publicado: (2010) -
Additional low-dose antimuscarinics can improve overactive bladder symptoms in patients with suboptimal response to beta 3 agonist monotherapy
por: Shin, Jung Hyun, et al.
Publicado: (2017) -
Factors affecting medication discontinuation in patients with overactive bladder symptoms
por: Shim, Eun-Jung, et al.
Publicado: (2015) -
The Prevalence and Therapeutic Effect of Constipation in Pediatric Overactive Bladder
por: Kim, Ji Hyun, et al.
Publicado: (2011) -
A Randomized, Double-Blind, Placebo-Controlled, Bridging Study to Evaluate the Efficacy and Safety of Vibegron in Treating Korean Patients With Overactive Bladder
por: Shin, Jung Hyun, et al.
Publicado: (2023)